Thanks furbush. I stopped checking clinicaltrials a while back so I was not aware. I'll be checking more frequently now as I am once again a shareholder.
I am not expecting any major appreciation until they have solid P2b data in humans. At this rate I don't see that happening until late 2015, more likely early 2016. Depends on when they start the actual trial. PD is not my favorite CEO in the world (to put it nicely) and I believe they'll likely do a big raise at some point in the future. The only reason why I am starting re-forming a small position again now despite what I just said above is because I don't know how many chances one will get to buy below a $60M market cap. I have my head on straight with this one and fully realize that it could go a lot lower than the current price through this transition and over the next few months. It is still worth the risk for me personally at these levels in my opinion for a small position. May not be for everyone, but this kind strategy has worked well for me over the last few years.
That's more like it. There is a way to express a negative sentiment, and then there is just behaving like a typical and boring yahoo troll. Glad to hear you say are going to tone it down. Thanks for this constructive thread madmaty76.
The way PD has guided, I doubt that is in the cards. Unfortunate in my opinion as I think that would go a long way in introducing ONCS to the big boys a la ADXS.
I actually did notice that in the PR about the collaboration with Mass General from the other day. I'm not sure why they omitted it, but I do think it is intentional...for whatever reason. It doesn't bother me too much as I am sure their hypothesis for combining IL-12 with anti-PD-1 hasn't changed. Heck Pierce's presentation tomorrow is on how current studies strongly support the combination of IL-12 with anti-PD-1.
It took you 20 missteps before you realized this? You actually thought investing in biotech was all about the science? Lol.
The fact that you just made these major breakthrough discoveries in your way of thinking explains why you are so excited to make a few peanuts in some other companies. It doesn't explain why you have to turn into a troll, but you were King Pumper for ONCS before you switched to the dark side, so I guess it's more of a personality issue than anything.
Anyhoo, congrats on making some profits after a year of frustrating losses with ONCS. Maybe keep the talk of other stocks out of this thread though. No one cares. That doesn't mean people don't invest in other companies. It means this is the ONCS board, to talk about ONCS. I am doing well in 2 other companies right now, but I am not going to spam the board about it and try and make people feel dumb for not seeing the light the way you finally have.
P.S. Connections and big money are just one part of it.
"At the effective time of the 1-for-20 reverse stock split, every 20 shares of issued and outstanding common stock will be converted into 1 share of issued and outstanding common stock, and the authorized shares of common stock will be reduced from 3,200,000,000 to 160,000,000 shares."
Here comes the expected volatility. I'll likely be adding more if it goes into the mid $4s and for sure if it makes it into the $3s at some point.
Here is a snippet from the PR from 10/08/13 talking about 100% regression in mice, how further studies will be done to test response in distant tumors, and how they plan to present findings in the future:
Dr. Richard Heller, professor at Old Dominion University, summarized the initial results of this study at the Cancer Vaccines and Gene Therapy Meeting in Philadelphia, Pennsylvania. The study was conducted using a single tumor model where a total of forty mice (eight treatment groups) were treated with either ImmunoPulse alone, or in combination with anti-CTLA4, anti-PD1 or both at varying concentrations. Safety and anti-tumor activity were assessed. Results indicate that all treatment groups showed 100% regression of treated lesions in all mice, and that no mice died as a result of toxicity from treatment. The results from this initial study demonstrate that ImmunoPulse in combination with anti-CTLA4 or anti-PD1 is safe, effective and does not have any contraindicated outcomes. Based on these positive results the company intends to continue testing combination approaches in more aggressive melanoma models that will support further evaluation of this approach in humans.
“Results are encouraging and indicate that using gene electrotransfer to deliver plasmid IL-12 into tumors can be an effective and safe delivery tool. Additional studies are being conducted to demonstrate that the combination may lead to immune responses against distant untreated lesions in mice. We will investigate the anti-tumor response and plan to present these findings in the near future,” commented Dr. Heller.
Good thoughts about the MCC data furbush and I agree that is a good possibility. I am actually more curious about the pre-clinical data, as that could be more tied into anti-PD-1. What was that pre-clinical data on rats that had 100% response? That has still yet to be presented correct?
The PR blitz is officially in full swing. Very interested to see what this data is and how it bolsters the theory for a combination approach.
I would not be surprised if they have a few more nugget PRs to put out in the next week/10 days.
No sal. You are entitled to your opinion and your sentiment. I could care less if you changed your sentiment and are now on the "other side". It is the way that you have become a troll trying to play the mightier-than-thou role by belittling others in your efforts to short the stock. There is a difference between being a bear and explaining your thesis for being so, and being a pr*ck. You are stuck in this yahoo message board mentality that being a bear means you also have to attack others and be the annoying basher. There are plenty of things I am not satisfied with regarding this stock, I just don't be a jerk about it.
If you are going to bring criticize furbush about telling people since the fall that this is the greatest stock in the planet, I'd suggest you go back and read some of your own over the top ridiculous pumper posts from the same time.
Look at all of these posts showing how phoney you are, lol. They are endless. I could keep bumping new ones for days.
Sal, look at you. You make a couple peanuts on a few stocks and you are like a giddy child in a toy store. Is this the first time you have ever made a profit on a stock? It sure seems like it. I have done pretty well in the market over the past few years. The difference is, when I make a significant return on investment, I don't feel the need to brag about it and try hard to pretend like I am a big man by belittling others.
P.S. Thank god I didn't follow your advice and buy AVXL yesterday. Down 12.5% since Monday morning, meanwhile I am up over 15% on my new ONCS shares! What a terrible terrible investor you are, what were you thinking!? What a joke blah blah, lol! (rolls eyes)
Again, you choose to frame the conversation to fit your narrative sal. Pretty weak, but after reading your posts for the past year I'd expect nothing less. I've lost my #$%$? Where do you get your info? Just to repeat though for those who didn't read the other threads. I bought ATHX in the $1.80s, started discussing it in the low $2s and it went up to $3.43 from there. Not my fault if people didn't sell when they had the chance. I have been out of ONCS since the $.40s and just started adding again at $.227.
Sadly you are the terrible investor. You have no idea what you are doing and admittedly latch onto the coat tails of others and depend on them to do DD for you. Thank god jbem came along for you or you would be continuing to throw darts at the board, lol.
I have held shares through 3 reverse splits before. I also use TD and what you are describing is pretty much in line with how it has transpired in times past.